Ozempic for weight loss is disrupting companies’ business model

  • 📰 mercnews
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 68%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Companies from Walmart Inc. to Conagra Brands Inc. are weighing how much to factor the diabetes drugs known as GLP-1s, increasingly being used for weight loss, into their strategies.

“Companies will overreact. The smart money will take action, but act slowly,” said Gary Stibel, chief executive officer of New England Consulting Group, which advises consumer and health care companies.

He recalled the olestra fad of the 1990s, when the fat substitute rapidly invaded the food aisle before being discarded due to its unpleasant side effects. “We’ve lived through what I think turned out to be a fad that we predicted would be a fad,” Richard Rosenfield, then an executive at California Pizza Kitchen, said in 2005. “It never seemed to affect our business. We did great through that craze.”

Even so, recent findings are eye-opening. A survey of GLP-1 users by Jefferies showed that more than 40% of respondents said they were eating out less. A similar percentage reported ordering less when they did. About 70% said they’re eating less overall, and roughly the same amount reported “increased awareness of nutritional benefits for foods.”

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 88. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Dialysis-company stocks slide after Ozempic trial's success in treating kidney diseaseDaVita’s stock was down 16%, while Baxter and Intuitive Surgical were down 9% and 6%
Sumber: MarketWatch - 🏆 3. / 97 Baca lebih lajut »

Stocks edge higher, 10-year auction on deck, Ozempic trial success, Exxon-Pioneer takeover, Delta Air...Stocks higher, 10-year auction, Ozempic, Exxon-Pioneer, Delta Air Lines
Sumber: startelegram - 🏆 248. / 63 Baca lebih lajut »